Health ❯ Vaccines

Vaccine Development

Ebola Vaccines mRNA Vaccines Clinical Trials Infectious Disease Vaccines Chikungunya Vaccines Experimental Vaccines Viral Vaccines Vaccine Availability Regulatory Affairs Public Health Policy

Study Maps Cross-Reactive T Cells Linking Measles and Nipah

Researchers say the shared T cell targets could guide vaccines that focus on conserved epitopes to broaden protection across paramyxoviruses.

Soligenix Highlights ThermoVax Thermostable Filovirus Vaccine Claims as Stock Surges

Pakistan Approves First National Vaccine Policy to Spur Local Production

India Says Nipah Cluster Contained as Asian Neighbors Tighten Airport Health Checks

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

Aid Cuts Linked to 200,000 More Child Deaths in 2025, Gates Foundation Warns

Ethiopia Confirms First Marburg Outbreak With Three Deaths in Omo Region

South Africa Begins Phase 1 Trials of First Locally Developed Oral Cholera Vaccine in 50 Years

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

Acting CDC Chief Calls to Split MMR Into Three Shots, Prompting Broad Pushback

WHO Logs 445,000 Chikungunya Cases in 2025 as New Studies Forecast Persistent Global Burden

Study Maps Lymphatic Endothelial Cell Program That Archives Antigens to Shape Immune Memory

Oxford Study Links Shingles and RSV Shots to Lower Dementia Risk

Europe Logs Record Chikungunya Outbreaks as Global Surge Intensifies

Lancet-Published NIH Study Reveals Children’s Immunity Gaps After COVID Measures

Kerala Confirms Second Nipah Case as Contact Tracing Expands

India Isolates Four New Omicron Sub-Variants During Latest COVID-19 Upsurge

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program

LC16m8 Vaccine Shows Strong Promise for Mpox Prevention in Latest Trials